Lindqvist E, Saxne T, Geborek P, Eberhardt K
Department of Rheumatology, Lund University Hospital, S-221 85 Lund, Sweden.
Ann Rheum Dis. 2002 Dec;61(12):1055-9. doi: 10.1136/ard.61.12.1055.
To investigate outcome as measured by health status, disease process, and damage in an unselected group of patients with early rheumatoid arthritis (RA) monitored prospectively for 10 years and to search for prognostic factors.
183 patients with RA with disease duration <2 years were assessed annually at a team care unit. Health status was measured by the Health Assessment Questionnaire (HAQ) and functional class. Disease process was assessed by clinical and laboratory measures of disease activity and evaluation of disease course. Damage was quantified as occurrence of major extra-articular manifestations and need for large joint replacements. Possible predictive factors were evaluated by logistic regression analyses.
168/183 patients completed the entire follow up period. Of all 183 patients, 137 (75%) had been treated with disease modifying antirheumatic drugs and 84 (46%) with low dose oral glucocorticoids. After 10 years 158 patients (94%) managed daily life activities independently (functional class I-II). As measured by the HAQ 20% had almost no disability, 28% were mildly disabled, and 10% were seriously disabled. Median HAQ score had increased from 0.8 to 1.1 (p<0.001). Disease activity was significantly reduced. 133 patients (79%) had a relapsing remitting disease course and 30 patients (18%) were in remission as defined by the American College of Rheumatology criteria. Thirty patients (17%) had undergone large joint replacements. Fifteen patients (8%) had developed major extra-articular complications. The HAQ score during the first three months predicted disability at 10 years with an odds ratio of 13.4.
Prospective studies such as this give important knowledge of the variable long term prognosis of RA and provide necessary background information for clinical trials of new treatment modalities.
在一组未经挑选的早期类风湿关节炎(RA)患者中,前瞻性监测10年,以健康状况、疾病进程和损害为指标调查结局,并寻找预后因素。
183例病程小于2年的RA患者在一个团队护理单元每年接受评估。健康状况通过健康评估问卷(HAQ)和功能分级进行测量。疾病进程通过疾病活动的临床和实验室指标以及疾病进程评估来评定。损害量化为主要关节外表现的发生情况以及大型关节置换的需求。通过逻辑回归分析评估可能的预测因素。
168/183例患者完成了整个随访期。在全部183例患者中,137例(75%)接受了改善病情抗风湿药物治疗,84例(46%)接受了低剂量口服糖皮质激素治疗。10年后,158例患者(94%)能够独立进行日常生活活动(功能分级为I-II级)。根据HAQ测量,20%的患者几乎没有残疾,28%为轻度残疾,10%为重度残疾。HAQ评分中位数从0.8增加至1.1(p<0.001)。疾病活动度显著降低。133例患者(79%)呈复发缓解型病程,30例患者(18%)根据美国风湿病学会标准处于缓解期。30例患者(17%)接受了大型关节置换。15例患者(8%)出现了主要关节外并发症。前三个月的HAQ评分预测10年时残疾的比值比为